Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Ablative Solutions: The company raised $76.9 million of Series 2 venture funding from undisclosed investors on November 26, 2025. The company is a developer of catheter-based...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Solve Therapeutics: The company raised $321 million of Series A venture funding in a deal led by Yosemite on November 17, 2025, putting the company’s pre-money valuation at...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Iambic: The company raised $100 million of Series B venture funding from EverBright, Regeneron Ventures and Wilson Sonsini Goodrich & Rosati on November 10, 2025, putting the...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Synchron: The company raised $200 million of Series D venture funding in a deal led by Double Point Ventures on November 6, 2025. Protocol Labs, IQTalent Partners, Qatar Holding, K5...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Tubulis: The company raised EUR 344 million of Series C venture funding in a deal led by Venrock on October 30, 2025. Andera Partners, Frazier Healthcare Partners, Blackstone,...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions OpenEvidence: The company raised $200 million of Series C venture funding in a deal led by GV on October 20, 2025, putting the company’s pre-money valuation at $5.8 billion....
